Cardiovascular Disease (CVD)

Orlistat Therapy for Obesity Linked to Fewer Major Adverse Cardiovascular Events

Publish Date July 29, 2021

A team of UK-based investigators explored the long-term cardiovascular outcomes in patients with obesity who were administered orlistat therapy.

Hyperuricemia Increases Risks for Cardiovascular, All-Cause Mortality

Publish Date July 27, 2021

Each 1 mg/dL rise in uric acid level was significantly associated with a 21% and 10% increased risk for cardiovascular and all-cause mortality, respectively, a study found.

Review: Benefit Outweighs Harm of Statins for Primary Prevention of CVD

Publish Date July 26, 2021

Risk for adverse events attributable to statins low when used for primary prevention of cardiovascular disease

Catheter Ablation Improves A-Fib Outcomes in Racial/Ethnic Minorities

Publish Date July 26, 2021

In contrast, much higher event rate seen for racial and ethnic minorities randomly assigned to drug therapy in CABANA trial

FDA Requests Removal of Pregnancy Contraindication for Statins

Publish Date July 23, 2021

The FDA conducted a comprehensive review of all available data associated with the use of statins during pregnancy.

Dapagliflozin Safe, Effective in Advanced Chronic Kidney Disease

Publish Date July 22, 2021

Dapagliflozin’s benefits among patients with stage 4 CKD were consistent with those observed in the larger DAPA-CKD cohort with stage 2-3 CKD.

Anemia, SHPT Are Possible Cardiovascular Risk Factors in Kidney Transplant Recipients

Publish Date July 22, 2021

In a small study, approximately a third of kidney transplant recipients had anemia and half had persistent secondary hyperparathyroidism.

Prior Statin Use Linked to Reduced Risk for Death in COVID-19

Publish Date July 22, 2021

Risk for death significantly reduced with prior statin and/or antihypertensive use among those with history of CVD and/or hypertension

Greater Daily Coffee Intake May Lower Risk for Arrhythmia

Publish Date July 22, 2021

No evidence of effect modification seen in interaction analyses using polygenic score with seven polymorphisms, CYP1A2 rs762551 alone

Iron Deficiency in CKD, With or Without Anemia, May Up Death, CV Risks

Publish Date July 21, 2021

Treating iron deficiency in patients with chronic kidney disease may be necessary even in the absence of anemia, according to investigators.